Literature DB >> 33761011

Telemental Health and the Management of Psychosis.

Amy L Donahue1, Jennifer Rodriguez2, Jay H Shore2,3.   

Abstract

PURPOSE OF REVIEW: The purpose of this paper is to review the application of telehealth in the assessment and treatment of psychotic illnesses. We present the contextual factors which make this approach to clinical care compelling, and review existing evidence about feasibility, acceptability, and effectiveness. RECENT
FINDINGS: The use of telehealth with individuals that suffer from serious mental illness and psychosis has been demonstrated to be feasible and acceptable, with effectiveness that is comparable to in-person clinical care. Telehealth holds the additional promises of expanding access, connecting patients, families, and the general public to behavioral health resources, and reducing overall health care costs. We provide two case examples which demonstrate the successful use of technology for the delivery and coordination of effective patient care for individuals with psychotic illnesses.

Entities:  

Keywords:  Acceptability; Effectiveness; Feasibility; Psychotic illness; Telemental health; Telepsychiatry

Mesh:

Year:  2021        PMID: 33761011      PMCID: PMC7989692          DOI: 10.1007/s11920-021-01242-y

Source DB:  PubMed          Journal:  Curr Psychiatry Rep        ISSN: 1523-3812            Impact factor:   5.285


Introduction

It is estimated that 1 in 5 adults in the USA, nearly 45 million people, lives with mental illness. Psychotic disorders alone have a lifetime prevalence of 3% [1]. Illness burden of such magnitude leads to profound human suffering and significant financial burden. The World Health Organization estimates that neuropsychiatric disorders lead to 33% of the global burden of total years lived with disability and an economic cost equivalent to approximately 2.5% of the US gross national product [2-4]. Individuals with severe mental disorders, including schizophrenia and bipolar disorder, have also been shown to die 10 to 20 years earlier than the general population, and those with psychosis have the highest relative risk for increased mortality [5, 6]. Longer duration of untreated psychosis is associated with cognitive deficits, reduced brain connectivity, more severe illness course, worse response to treatment, and decreased quality of life [7-12]. These poor outcomes make a patient linkage with specialty care providers essential to alter health outcome trajectories. Unfortunately, it is estimated that nearly half of all adults in need of behavioral health care do not receive the needed treatment. There are numerous barriers to treatment for those suffering from mental illness. For those individuals with psychosis, when early symptoms may be subtle and difficult to detect, the nature of the illness can lead to a lack of insight and awareness about the need for treatment. In addition, mental health workforce shortages throughout the country have been well documented. According to a 2016 SAMSA report on rural behavioral health, it is estimated that more than 75% of all US counties are mental health workforce shortage areas and half of all US counties have no mental health professionals at all. Rurality and per capita income have been shown to be predictors of this shortfall [13, 14]. The use of telehealth has emerged as one solution to improving access to behavioral health care [15].

Telehealth as a Solution

According to the American Telemedicine Association, telehealth can be defined as “technology-enabled health and care management and delivery systems that extend capacity and access” [16]. Services can be provided using an array of different formats and delivery systems, which allow for provider consultation, patient assessment and monitoring, ongoing treatment, and psychoeducation (Fig. 1).
Fig. 1

Examples of telehealth service

Examples of telehealth service Technology has been used in community and home-based care for centuries [17]. The US Department of Health and Human Services estimates that nearly half of all health care institutions and hospitals currently use some form of telehealth, and according to the American Medical Association, physician utilization of digital health has increased in recent years, particularly when it is viewed as a tool to improve efficiency and patient safety [18, 19]. Reimbursement and parity laws also significantly influence the use the telehealth, which in the era of COVID-19 have improved under legislative changes and the emergency declaration status [20, 21]. In 2018, The American Psychiatric Association and the American Telemedicine Association released an updated practice guideline to inform best practice standards for videoconferencing-based telemental health [22••]. The document provides important guidance for the development and implementation of a telemental health program, with recommendations drawn from the evidence base which supports the safety and efficacy of this approach to clinical care. Recent reviews have demonstrated the feasibility, acceptability, and effectiveness of telepsychiatry; however, many do not specifically focus on the potential benefits for individuals with psychosis [23, 24]. While psychotic illness tends to be less common than mental health conditions like depression and anxiety, the associated elevated risk of morbidity and mortality makes the application of telehealth in this population a worthwhile focus of study.

Telehealth and Psychotic Illness

There has been an international effort to systematically review the evidence base for the application of telehealth for individuals with severe mental illness and psychosis. While differing study methods and definitions of telehealth modalities at times make interpretation of the evidence challenging, there are clear efforts underway to broaden our understanding of the potential benefits of telehealth for the assessment and treatment of patients with psychosis [25, 26, 27••, 28]. One particularly useful review was published in 2016 by the European Psychiatric Association, which offered a set of 5 graded recommendations for telehealth interventions, based on the quality of the evidence to date [29•]. What appears to be consistently demonstrated in systematic reviews is the feasibility of delivering care via telehealth in its various forms, including the utilization of videoconferencing technology, internet-based programs, and mobile health applications [30, 31]. A finding of additional promise is the general acceptability of telehealth by both service users and providers. As it can be the nature of psychosis for individuals to have ideas of reference, it is an understandable concern that the use of videoconferencing could trigger an exacerbation of symptoms. Fortunately, with rare exception, this experience has not been borne out in the literature [27••, 28]. In fact, many service users have expressed preferring this type of delivery system due to the convenience. One could also speculate that the physical separation that is provided by telehealth can lead to a sense of security and control that could decrease anxiety for psychotic patients, as demonstrated in some other reports in telehealth treatments of anxiety [32]. Patient assessments that are conducted using videoconferencing have been found to be equivalent to face-to-face assessments in controlled studies, which speaks to the reliability of this approach. Reliability appears to be additionally enhanced when providers use a higher speed internet connection. The poorer quality of lower bandwidth has been shown to potentially impair the ability to assess the more subtle negative symptoms of schizophrenia, although this association has not been consistently demonstrated [26, 28]. Finally, the use of telehealth has been shown to lead to improvements in patient outcomes. The use of mobile health technology and telephonic interventions have been shown to lead to improved medication compliance and increased attendance at medication management appointments [25, 30]. A controlled study has demonstrated the reliability of administering the Abnormal Involuntary Movement Scale (AIMS) over videoconferencing, although in-person exams may be required to monitor other movement disorder symptoms not addressed in the AIMS (e.g., cogwheeling). Mobile health applications additionally show promise for symptom tracking, relapse prevention, and illness self-management [30-34]. Innovative programs have also been developed and have been shown to improve cognitive and social functioning for individuals with serious mental illness, including the application of virtual reality technology for social skills training and enhancement of work performance [25]. Patients have also reported a reduction in symptom severity when receiving care through telehealth, as measured by standardized assessment tools including the Brief Psychiatric Rating Scale (BPRS) and the Positive and Negative Syndrome Scale (PANSS). Improvements were found to be comparable to reported improvements when a patient received in-person care [28, 29•]. Below, we present two clinical cases from our work intended to illustrate common themes and issues that can arise when working with patients dealing with psychotic illness.

Case Example 1

“Jacob” is a 23-year-old male who was referred for psychiatric consultation following a hospital admission for treatment of an acute psychotic episode. At the time of his initial outpatient assessment, Jacob was residing in a small remote rural community. Jacob’s mother brought him to the appointment, and she provided background information. Jacob met with the psychiatrist via videoconferencing, and while he presented with grandiose delusional beliefs, he denied hallucinations and was able to provide basic information about his medication regimen. He was started on an oral antipsychotic medication in the hospital and due to his ongoing symptoms, the dose was increased and converted to a long-acting injectable formulation. Jacob’s psychiatrist and family worked with his primary care provider to coordinate needed laboratory monitoring and medication injections. Ancillary staff at the primary care provider’s office were also able to call Jacob and his mother to remind them of appointments and facilitated linkage to a local mental health clinician to assist Jacob in meeting his goals of completing a GED and finding employment. Throughout the course of his treatment, Jacob was consistent with follow-up appointments, was compliant with nursing visits and medication administration, presented clinically with a reduction in psychotic symptoms, and was able to sustain housing and regular employment. This case helps to demonstrate the ability of telehealth to provide critical access to psychiatric services for patients dealing with psychosis in remote and rural communities. It also shows the criticality, and need of this case, to involve both family members and team members at the patient side to support compliance and case management functions to address both logistical treatment concerns (eg. labs and injections) and social determinants of health (eg. education and employment).

Case Example 2

“Paul” is a 17-year-old male who was referred for psychiatric consultation following a visit with his primary care provider, where he presented with auditory hallucination after reportedly smoking LSD-laced marijuana. His appointment was scheduled through his primary care provider, who had a relationship with a behavioral health clinician to provide diagnostic assessments and treatment via videoconferencing. Paul was brought to the appointment by his paternal aunt, uncle, and older brother, with whom he was residing. They provided transportation and background information for the completion of the assessment. Paul’s aunt reported that within the past week they had taken him to the emergency room because of his symptoms. They were told he should be better in a week or two and sent the family home. Paul then called the police twice during the past week due to auditory hallucinations, became increasingly paranoid, and locked himself in his room and at one point, jumped out the second-floor apartment window, and ran down the street. When his family caught up with him, he became physically aggressive toward his uncle. Paul’s family reported concern for his safety and due to his increasing psychosis, they did not think they could continue to safely care for him. Paul had difficulty engaging in the assessment with the telehealth clinician via videoconferencing. He appeared guarded and reported paranoid delusions that the telehealth clinician was recording the session. Paul also reported visual and command auditory hallucinations, seeing “shadows” and hearing the television telling him “don’t go, run.” Paul’s telehealth clinician, family, and primary care team worked together to transfer Paul to the hospital for additional assessment. Paul was admitted to an inpatient behavioral health unit where he was diagnosed with schizophrenia. He was started on effective treatment and his family was educated about his diagnosis, which enabled safe discharge to home with coordinated aftercare. This second case differs from the first in the ability of the patient to cooperate and engage in the assessment as well as having the videoconference interplay with his psychotic symptoms. Despite this, telehealth played an important role in the necessary assessment, triage, and connection to care that led to a positive outcome during this episode. The telehealth behavioral health clinician had to assess the extent of Paul to engage in his assessment vs. working with the wider support of his family and team on the ground to manage the situation. The fundamental principles of engaging wider collaterals and on-site team members would not defer for the clinician had they been physically present with Paul. This counters the concerns of videoconferencing exacerbating or not being appropriate for use in psychosis especially if it gets incorporated into the psychotic processes.

Discussion

We proffer the following key considerations for clinicians and services working through telehealth with psychotic illnesses. Create detailed clinical workflows, procedure, and protocols that account for the needs of this patient population. This includes having good safety protocols, knowing local commitment processes, connection to local resources and emergency services, and procedures for obtaining working with collateral contacts, and ordering and obtaining results of necessary testing (e.g., labs). Assess and develop awareness of the patient’s current mental status with attention to psychotic symptoms and whether these are involving the technology being used. Assess the patient’s level of reality testing if they are experiencing psychotic symptoms involving technology, whether these are general or specific to the telehealth being used, and the patient’s ability to distinguish these. If the patient is demonstrating difficulty with reality testing around technology, be sure to immediately engage local staff support and family members where clinically appropriate. Leverage technology for gathering of collateral information and in-between patient session contacts. For the patient with chronic severe mental illness (SMI), consider using virtual home visits to assess function and care needs. While technology has been used for centuries in the delivery of health care, it has not been until more recently that its application in the treatment of psychotic illnesses has been explored. Due to the increased risk for morbidity and mortality in individuals with SMI, it is worthwhile to explore potential opportunities to engage people with the needed resources and care. Associated increased rates of homeless and lower SES in individuals with SMI compound existing barriers to accessing mental health care and the current logistical challenges presented by COVID restrictions further threaten to widen the health disparity gap [35-37]. Findings suggest that the development and implementation of telehealth for the treatment of psychotic illnesses is feasible and acceptable and leads to outcomes which are aligned with best practices and standards of care for psychotic illnesses [38]. The use of telehealth and mobile devices has shown promise to meet the unique needs of patients with SMI, including mobile health programs that have delivered care to homeless youth, monitored suicidal ideation in patients with schizophrenia post-hospital discharge, and provided clozapine monitoring in the era of distance clinical care [39-41]. Not only can telehealth be used to improve access to behavioral health providers and quality care but has the potential to provide patients, families, and the general public with information that can be used to promote mental health awareness and early detection, assist with system navigation, and decrease the stigma surrounding mental illness [42•]. The use of telehealth also has the potential to decrease healthcare costs. Studies of health care utilization found decreased emergency room visits and inpatient days when psychotic patients received remote telemonitoring of medication compliance and symptoms when compared to care as usual [25]. Utilizing telehealth to integrate behavioral health care into the primary care setting, as reflected in the case examples, is an additional novel approach worth considering. The cost-saving benefits of integrated care have been well established through extensive actuarial analysis of the health care marketplace [43]. Integrated care provides benefits of improving linkage of patients with SMI, in lieu of the well-known findings that patients with SMI have shorter life spans due to excess mortality due to physical illness and are less likely to receive the same standard and quality of care [44]. It is important to balance the myriad potential benefits of telehealth with possible barriers to implementation. Practice transformation can be challenging, and successful implementation of telehealth programs requires buy in from key stakeholders including providers, health care systems, and users. Engagement can be facilitated by creating user-friendly systems and providing education about the value of technology and system integration for improving health outcomes.

Conclusions

The use of telehealth to provide care to individuals with psychotic illnesses is an important and worthwhile focus of study. While opportunities remain to build our evidence base, particularly separating out the application and efficacy of the various telehealth modalities for differing facets of care, there appear to be potential benefits for this approach to clinical care.
  33 in total

1.  Review of key telepsychiatry outcomes.

Authors:  Sam Hubley; Sarah B Lynch; Christopher Schneck; Marshall Thomas; Jay Shore
Journal:  World J Psychiatry       Date:  2016-06-22

Review 2.  Telehealth interventions for schizophrenia-spectrum disorders and clinical high-risk for psychosis individuals: A scoping review.

Authors:  Olga Santesteban-Echarri; Danijela Piskulic; Rowen K Nyman; Jean Addington
Journal:  J Telemed Telecare       Date:  2018-08-22       Impact factor: 6.184

3.  Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care.

Authors:  Marc DE Hert; Christoph U Correll; Julio Bobes; Marcelo Cetkovich-Bakmas; Dan Cohen; Itsuo Asai; Johan Detraux; Shiv Gautam; Hans-Jurgen Möller; David M Ndetei; John W Newcomer; Richard Uwakwe; Stefan Leucht
Journal:  World Psychiatry       Date:  2011-02       Impact factor: 49.548

4.  The use of videoconferencing with patients with psychosis: a review of the literature.

Authors:  Ian R Sharp; Kenneth A Kobak; Douglas A Osman
Journal:  Ann Gen Psychiatry       Date:  2011-04-18       Impact factor: 3.455

Review 5.  Mortality in mental disorders and global disease burden implications: a systematic review and meta-analysis.

Authors:  Elizabeth Reisinger Walker; Robin E McGee; Benjamin G Druss
Journal:  JAMA Psychiatry       Date:  2015-04       Impact factor: 21.596

Review 6.  Telepsychiatry in the assessment and treatment of schizophrenia.

Authors:  John Kasckow; Kandi Felmet; Cathleen Appelt; Robert Thompson; Armando Rotondi; Gretchen Haas
Journal:  Clin Schizophr Relat Psychoses       Date:  2014-04

7.  Prolonged duration of untreated psychosis: a problem that needs addressing.

Authors:  Jack Cotter; Elisabeth Zabel; Paul French; Alison R Yung
Journal:  Early Interv Psychiatry       Date:  2016-01-23       Impact factor: 2.732

8.  A Population-Based Cohort Study Examining the Incidence and Impact of Psychotic Experiences From Childhood to Adulthood, and Prediction of Psychotic Disorder.

Authors:  Sarah A Sullivan; Daphne Kounali; Mary Cannon; Anthony S David; Paul C Fletcher; Peter Holmans; Hannah Jones; Peter B Jones; David E J Linden; Glyn Lewis; Michael J Owen; Michael O'Donovan; Alexandros Rammos; Andrew Thompson; Dieter Wolke; Jon Heron; Stanley Zammit
Journal:  Am J Psychiatry       Date:  2020-01-07       Impact factor: 18.112

9.  Excess mortality in persons with severe mental disorders: a multilevel intervention framework and priorities for clinical practice, policy and research agendas.

Authors:  Nancy H Liu; Gail L Daumit; Tarun Dua; Ralph Aquila; Fiona Charlson; Pim Cuijpers; Benjamin Druss; Kenn Dudek; Melvyn Freeman; Chiyo Fujii; Wolfgang Gaebel; Ulrich Hegerl; Itzhak Levav; Thomas Munk Laursen; Hong Ma; Mario Maj; Maria Elena Medina-Mora; Merete Nordentoft; Dorairaj Prabhakaran; Karen Pratt; Martin Prince; Thara Rangaswamy; David Shiers; Ezra Susser; Graham Thornicroft; Kristian Wahlbeck; Abe Fekadu Wassie; Harvey Whiteford; Shekhar Saxena
Journal:  World Psychiatry       Date:  2017-02       Impact factor: 49.548

10.  Telephonic monitoring of patients on clozapine in the resource-poor setting during the COVID-19 pandemic.

Authors:  Sandeep Grover; Eepsita Mishra; Subho Chakrabarti; Aseem Mehra; Swapnajeet Sahoo
Journal:  Schizophr Res       Date:  2020-05-28       Impact factor: 4.939

View more
  3 in total

1.  The Competencies of Telehealth Peer Support: Perceptions of Peer Support Specialists and Supervisors During the COVID-19 Pandemic.

Authors:  Amy B Spagnolo; Carlos W Pratt; Yuane Jia; Matthew DeMasi; Rita Cronise; Kenneth Gill
Journal:  Community Ment Health J       Date:  2022-02-11

2.  Metacognitive Reflection and Insight Therapy (MERIT) Delivered Virtually During the COVID-19 Pandemic: An Illustration of Two Cases.

Authors:  Laura A Faith; Denise S Zou; Marina Kukla
Journal:  J Contemp Psychother       Date:  2022-08-10

3.  Comparison of Healthcare Utilization Between Telemedicine and Standard Care: A Propensity-Score Matched Cohort Study Among Individuals With Chronic Psychotic Disorders in Ontario, Canada.

Authors:  Ahmad Shakeri; Cherry Chu; Vess Stamenova; Jiming Fang; Lucy C Barker; Simone N Vigod; R Sacha Bhatia; Mina Tadrous
Journal:  Schizophr Bull Open       Date:  2022-07-22
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.